Stockscreener 앱 받기
12.01
0.58%
-0.07
시간 외 거래:
12.01
Evolus Inc 주식(EOLS)의 최신 뉴스
Evolus Secures New $250 Million Credit Facility - TipRanks
Evolus IncEnters New $250 Million Credit Facility With Pharmakon Advisors, Replacing Exisiting $125 Million Credit Agreement - marketscreener.com
Evolus Strengthens Balance Sheet with Refinancing; Reducing Cost of Capital and Expanding Financial Flexibility | EOLS Stock News - GuruFocus
Evolus Strengthens Balance Sheet with Refinancing; Reducing Cost of Capital and Expanding Financial Flexibility - Business Wire
Analysts Offer Insights on Healthcare Companies: Align Tech (ALGN), Evolus (EOLS) and Becton Dickinson (BDX) - The Globe and Mail
Will Evolus, Inc. (EOLS) Report Negative Earnings Next Week? What You Should Know - Yahoo Finance
When Will Evolus, Inc. (NASDAQ:EOLS) Breakeven? - simplywall.st
Evolus Inc (EOLS) Shares Gap Down to $11.115 on Apr 28 - GuruFocus
Midday Stock Roundup: FivePoint Rises on Earnings - Orange County Business Journal
Evolus to Report First Quarter Financial Results on May 7, 2025 - BioSpace
Evolus: Two-Product Aesthetics Company With A Competitive Edge (NASDAQ:EOLS) - Seeking Alpha
Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | EOLS Stock News - GuruFocus
Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
Evolus announces commercial launch of Evolysse - MSN
BTIG Initiates Coverage of Evolus (EOLS) with Buy Recommendation - Nasdaq
BTIG Initiates Evolus at Buy With $21 Price Target - marketscreener.com
Evolus initiated with a Buy at BTIG - TipRanks
BTIG Initiates Coverage on Evolus (EOLS) with Optimistic Outlook | EOLS Stock News - GuruFocus
BTIG Initiates Coverage on Evolus (EOLS) with Optimistic Outlook - GuruFocus
Evolus Launches "Drop The F Word" To Redefine Aesthetic Injectables With Evolysse - Nasdaq
Evolus Announces Commercial Launch of Evolysse™ | EOLS Stock New - GuruFocus
Evolus Announces Commercial Launch of Evolysse™ - Yahoo Finance
Evolus Launches “Drop the F Word” Campaign in Advance of the Com - GuruFocus
Game-Changing Cold-X Technology: Evolus Revolutionizes Injectable Aesthetics with Natural Results - Stock Titan
Midday Stock Roundup: Evolus, ICU Medical down - Orange County Business Journal
H.C. Wainwright maintains Buy on Evolus stock with $27 target - Investing.com
H.C. Wainwright maintains Buy on Evolus stock with $27 target By Investing.com - Investing.com Canada
Evolus stock hits 52-week low at $9.22 amid market challenges - Investing.com Canada
Evolus stock hits 52-week low at $9.22 amid market challenges By Investing.com - Investing.com South Africa
Breaking Down Evolus: 8 Analysts Share Their Views - Benzinga
Investors Give Evolus, Inc. (NASDAQ:EOLS) Shares A 31% Hiding - simplywall.st
Evolus at Needham Conference: Strategic Launch of Evolisse By Investing.com - Investing.com Canada
Evolus at Needham Conference: Strategic Launch of Evolisse - Investing.com
Sandra Beaver: Evolus on Track to Hit $700M Revenue - Orange County Business Journal
Recent 11% pullback isn't enough to hurt long-term Evolus (NASDAQ:EOLS) shareholders, they're still up 170% over 5 years - simplywall.st
Evolus, Inc.: Navigating Financial Challenges Amidst Ongoing Losses and Market Uncertainty - MSN
Evolus CEO David Moatazedi sells $77,512 in stock By Investing.com - Investing.com India
Evolus CEO David Moatazedi sells $77,512 in stock - Investing.com Australia
Evolus to Participate in The Needham 24th Annual Virtual Healthcare Conference - BioSpace
Evolus Inc (EOLS) Shares Down 4.54% on Mar 25 - GuruFocus
Investing in Evolus (NASDAQ:EOLS) five years ago would have delivered you a 216% gain - Yahoo
Evolus reports inducement grants under Nasdaq listing rule 5635(C)(4) -March 21, 2025 at 04:17 pm EDT - MarketScreener
Evolus director David Moatazedi sells $1.37 million in stock By Investing.com - Investing.com Australia
Evolus Growth Continues: 14 New Employees Join as Company Strengthens Talent Pool - Stock Titan
Evolus to Participate in Canaccord Genuity’s 43rd Annual Growth Conference - Business Wire
1.20%
0.06%
자본화:
|
볼륨(24시간):